ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $268,000 | -25.3% | 4,488 | -9.3% | 0.04% | -5.1% |
| Q1 2022 | $359,000 | -13.7% | 4,947 | +0.0% | 0.04% | -9.3% |
| Q4 2021 | $416,000 | -11.9% | 4,946 | -12.1% | 0.04% | -28.3% |
| Q3 2021 | $472,000 | -12.1% | 5,629 | +0.0% | 0.06% | -20.0% |
| Q2 2021 | $537,000 | -25.4% | 5,628 | -11.1% | 0.08% | -39.5% |
| Q1 2021 | $720,000 | -18.2% | 6,328 | -0.4% | 0.12% | -31.5% |
| Q4 2020 | $880,000 | +60.3% | 6,354 | -4.8% | 0.18% | +39.2% |
| Q3 2020 | $549,000 | – | 6,674 | +111133.3% | 0.13% | – |
| Q1 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |